Meckler Jeffrey A 13D and 13G filings for Indaptus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-26 4:11 pm Purchase | 2024-11-22 | 13D | Indaptus Therapeutics, Inc. INDP | Meckler Jeffrey A | 875,704 6.900% | 85,106 (+10.76%) | Filing |
| 2024-10-10 4:10 pm Purchase | 2023-08-04 | 13D | Indaptus Therapeutics, Inc. INDP | Meckler Jeffrey A | 790,598 7.300% | 790,598 (New Position) | Filing |